# The Effect of Sifrol® on Tremor and Depression in Patients With Idiopathic Parkinson's Disease

> **NCT02231294** · — · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 1464 (actual)

## Conditions studied

- Parkinson Disease

## Interventions

- **DRUG:** Sifrol®

## Key facts

- **NCT ID:** NCT02231294
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2000-07
- **Primary completion:** 2002-01
- **Final completion:** —
- **Target enrollment:** 1464 (ACTUAL)
- **Last updated:** 2014-09-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02231294

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02231294, "The Effect of Sifrol® on Tremor and Depression in Patients With Idiopathic Parkinson's Disease". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT02231294. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*